Effect of Lactic Acid Bacteria on the Regulation of Blood Glucose Level in Streptozotocin-induced Diabetic Rats

  • Received : 2010.11.25
  • Accepted : 2010.12.03
  • Published : 2010.12.31


To identify the treatment effect of lactic acid bacteria for diabetes, the treatment effects of a single administration of acarbose (a diabetes treatment drug) or lactic acid bacteria, and the mixture of acarbose and lactic acid bacteria on diabetes in a type 1 diabetes animal model, were studied. In this study, streptozotocin was inoculated into a Sprague-Dawley rat to induce diabetes, and sham control (Sham), diabetic control (STZ), STZ and composition with live cell, STZ and composition with heat killed cell, STZ and composition with drugs (acarbose) were orally administered. Then the treatment effect on diabetes was observed by measuring the body weight, blood glucose, and serum lipid. For the histopathological examination of the pancreas, the Langerhans islet of the pancreas was observed using hematoxylin and eosin staining, and the renal cortex, outer medullar, and inner medullar were also observed. The induced diabetes decreased the body weight, and the fasting blood glucose level decreased in the lactic-acid-bacteria-administered group and the mixture-administered group. In addition, the probiotic resulted in the greatest decrease in the serum cholesterol level, which is closely related to diabetes. Also, the hematoxylin and eosin staining of the Langerhans islet showed that the reduction in the size of the Langerhans islet slowed in the lactic-acid-bacteria-administered group. The histopathological examination confirmed that the symptoms of diabetic nephropathy decreased in the group to which viable bacteria and acarbose were administered, unlike in the group to which dead bacteria was administered. The mixture of lactic acid bacteria and acarbose and the single administration of lactic acid bacteria or acarbose had treatment effects on the size of the Langerhans islet and of the kidney histopathology. Thus, it is believed that lactic acid bacteria have treatment effects on diabetes and can be used as supplements for the treatment of diabetes.


  1. Al-Wakeel JS, Hammad D, Al Suwaida A, Mitwalli AH, Memon NA, Sulimani F (2009): Microvascular and macrovascular complications in diabetic nephropathy patients referred to nephrology clinic. Saudi J Kidney Dis Transpl 20:77-85.
  2. Babu PS, Stanely Mainzen Prince P (2004): Antihyperglycaemic and antioxidant effect of hyponidd, an ayurvedic herbomineral formulation in streptozotocininduced diabetic rats. J Pharm Pharmacol 56:1435-1442. https://doi.org/10.1211/0022357044607
  3. Beckman JA, Creager MA, Libby P (2002): Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. Jama 287:2570-2581. https://doi.org/10.1001/jama.287.19.2570
  4. Cantenys D, Portha B, Dutrillaux MC, Hollande E, Roze C, Picon L (1981): Histogenesis of the endocrine pancreas in newborn rats after destruction by streptozotocin. An immunocytochemical study. Virchows Arch B Cell Pathol Incl Mol Pathol 35:109-122.
  5. Chiu CH, Lu TY, Tseng YY, Pan TM (2006): The effects of Lactobacillus-fermented milk on lipid metabolism in hamsters fed on high-cholesterol diet. Appl Microbiol Biotechnol 71:238-245. https://doi.org/10.1007/s00253-005-0145-0
  6. Clissold SP, Edwards C (1988): Acarbose. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential. Drugs 35:214-243.
  7. Hayden MR, Tyagi SC, Kerklo MM, Nicolls MR (2005): Type 2 diabetes mellitus as a conformational disease. Jop 6:287-302.
  8. Hochgrafe F, Wolf C, Fuchs S, Liebeke M, Lalk M, Engelmann S, Hecker M (2008): Nitric oxide stress induces different responses but mediates comparable protein thiol protection in Bacillus subtilis and Staphylococcus aureus. J Bacteriol 190:4997-5008. https://doi.org/10.1128/JB.01846-07
  9. Junod A, Lambert AE, Orci L, Pictet R, Gonet AE, Renold AE (1967): Studies of the diabetogenic action of streptozotocin. Proc Soc Exp Biol Med 126: 201-205. https://doi.org/10.3181/00379727-126-32401
  10. Kato I, Endo K, Yokokura T (1994): Effects of oral administration of Lactobacillus casei on antitumor responses induced by tumor resection in mice. Int J Immunopharmacol 16:29-36. https://doi.org/10.1016/0192-0561(94)90116-3
  11. Kawada J (1992): New hypotheses for the mechanisms of streptozotocin and alloxan inducing diabetes mellitus. Yakugaku Zasshi 112:773-791. https://doi.org/10.1248/yakushi1947.112.11_773
  12. Kim HS (2005): The effects of Prunus persica Batsch var. davidiana Max. Hot-water extract on the lipid peroxide and creatine phosphokinase activity in streptozotocin- induced diabetic rats. J Food & Nutr 18: 272-278.
  13. Kim JE, Kim JY, Lee KW, Lee HJ (2007): Cancer chemopreventive effects of lactic acid bacteria. J Microbiol Biotechnol 17:1227-1235.
  14. Lane P, Steffes MW, Mauer SM (1991): Structural-functional relationships in type I insulin-dependent diabetes mellitus in humans. J Diabet Complications 5:69-71. https://doi.org/10.1016/0891-6632(91)90021-G
  15. Leonhardt W, Hanefeld M, Fischer S, Schulze J (1994): Efficacy of alpha-glucosidase inhibitors on lipids in NIDDM subjects with moderate hyperlipidaemia. Eur J Clin Invest 24 Suppl 3:45-49.
  16. Lupi R, Del Prato S (2008): Beta-cell apoptosis in type 2 diabetes: quantitative and functional consequences. Diabetes Metab 34 Suppl 2:S56-64. https://doi.org/10.1016/S1262-3636(08)73396-2
  17. Ouwehand AC, Salminen S, Isolauri E (2002): Probiotics: an overview of beneficial effects. Antonie Van Leeuwenhoek 82:279-289. https://doi.org/10.1023/A:1020620607611
  18. Perdigon G, Nader de Macias ME, Alvarez S, Oliver G, Pesce de Ruiz Holgado AA (1990): Prevention of gastrointestinal infection using immunobiological methods with milk fermented with Lactobacillus casei and Lactobacillus acidophilus. J Dairy Res 57:255-264. https://doi.org/10.1017/S002202990002687X
  19. Shahani KM, Ayebo AD (1980): Role of dietary lactobacilli in gastrointestinal microecology. Am J Clin Nutr 33:2448-2457. https://doi.org/10.1093/ajcn/33.11.2448
  20. Shida K, Makino K, Morishita A, Takamizawa K, Hachimura S, Ametani A, Sato T, Kumagai Y, Habu S, Kaminogawa S (1998): Lactobacillus casei inhibits antigen-induced IgE secretion through regulation of cytokine production in murine splenocyte cultures. Int Arch Allergy Immunol 115:278-87. https://doi.org/10.1159/000069458
  21. Yoon JA, Son YS (2009): Effect of Opuntiaficus-indica complexes B (OCB) on blood glucose and lipid metabolism in stereptocin-induced diabetic rats. J Food & Nutr 22:48-56.